Latest news about Intuitive Surgical
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
Intuitive Surgical's Q3 2024 saw robust growth: 379 da Vinci systems placed, an 18% year-over-year increase in procedures, and a 17% rise in revenue to $2.04 billion. The da Vinci 5, cleared by the FDA in March, has been installed in 188 sites, with over 12,000 procedures completed, and is set for a broader launch in mid-2025[1][2][5].
Intuitive Surgical's da Vinci 5, after receiving FDA clearance in March, has seen significant adoption with 188 systems installed and over 12,000 procedures completed. The system features advanced technologies like force feedback sensing, improved ergonomics, and a smaller footprint. A broader launch is anticipated by mid-2025, with regulatory approvals in South Korea and a CE mark submission in Europe underway[1][3][5].
Intuitive Surgical reported a 36% increase in net income to $565 million for Q3 2024, with a 17% rise in revenue to $2.04 billion. The company's profit margin increased to 28%, and EPS surpassed analyst estimates by 17%. The da Vinci 5 has received clearance in South Korea and is awaiting a CE mark in Europe, with a broader launch expected in mid-2025[1][2][3].
Open job positions at Intuitive Surgical
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.